An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis

Published:2022-08-24 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Arabpour Mohammad¹,Paul Sanchari¹,Grauers Wiktorin Hanna¹,Kaya Mustafa¹,Kiffin Roberta¹,Lycke Nils²,Hellstrand Kristoffer¹,Martner Anna¹^ORCID

Affiliation:

1. TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Mucosal Immunobiology and Vaccine Center, Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Funder

The Swedish Research Council

The Swedish Cancer Society

The Swedish state via the ALF

The Wilhelm and Martina Lundgren Research Foundation (SP); The Sahlgrenska Academy at University of Gothenburg

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2115618

Reference42 articles.

1. Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination

2. Directing dendritic cell immunotherapy towards successful cancer treatment

3. Cancer immunotherapy via dendritic cells

4. A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the niche for stem-like CD8+ T cell formation and function;Current Opinion in Immunology;2024-08

2. Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1;Molecular Therapy;2024-07

3. Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines;BME Frontiers;2024-01

4. Trial watch: chemotherapy-induced immunogenic cell death in oncology;OncoImmunology;2023-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3